Cochrane · systematic review · CD005336

Psychosocial interventions for cannabis use disorder

Gates, PJ, Sabioni, P, Copeland, J, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

Drugs and AlcoholAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 16.7%Low 3 · 50%Moderate 2 · 33.3%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: adults with cannabis use disorder or frequent cannabis use
6 questions
OutcomeEffectEvidenceStatus / GRADE
Cannabis use frequency at short‐term
MD 5.67 [3.08, 8.26]6 studies · 1144 participantsModerate
Downgraded: risk of bias, imprecision
Point‐prevalence abstinence rates at short‐term
RR 2.55 [1.34, 4.83]6 studies · 1166 participantsLow
Downgraded: risk of bias, imprecision
Cannabis use quantity per day at short‐term
SMD 3.55 [2.51, 4.59]8 studies · 1600 participantsVery low
Downgraded: risk of bias, imprecision
Symptoms of dependence at short‐term
SMD 4.15 [1.67, 6.63]4 studies · 889 participantsLow
Downgraded: risk of bias, imprecision
Cannabis‐related problems at short‐term
SMD 3.34 [1.26, 5.42]6 studies · 2202 participantsLow
Downgraded: risk of bias, imprecision
Retention in treatment
no estimate extracted11 studies · 1424 participantsModerate
Downgraded: risk of bias, imprecision